EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy

Kenji Makita, Yasushi Hamamoto, Hiromitsu Kanzaki, Kei Nagasaki, Noriko Takata, Shintaro Tsuruoka, Kotaro Uwatsu, Teruhito Kido

Medical Sciences · 2023

DOI: 10.3390/medsci11010017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2023. Verfasst von Kenji Makita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon 791-0295, Ehime, Japan. Hauptthemen laut MEDLINE: Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate the expected prognosis and factors affecting local control (LC) of the bone metastatic sites treated with palliative external beam radiotherapy (RT). Between December 2010 and April 2019, 420 cases (male/female = 240/180; median age [range]: 66 [12–90] years) with predominantly osteolytic bone metastases received RT and were evaluated. LC was evaluated by follow-up computed tomography (CT) image. Median RT doses (BED10) were 39.0 Gy (range, 14.4–71.7 Gy). The 0.5-year overall survival and LC of RT sites were 71% and 84%, respectively. Local recurrence on CT images was observed in 19% (n = 80) of the RT sites, and the median recurrence time was 3.5 months (range, 1–106 months). In univariate analysis, abnormal laboratory data before RT (platelet count, serum albumin, total bilirubin, lactate dehydrogenase, or serum calcium level), high-risk primary tumor sites (colorectal, esophageal, hepatobiliary/pancreatic, renal/ureter, and non-epithelial cancers), no antineoplastic agents (ATs) administration after RT, and no bone modifying agents (BMAs) administration after RT were significantly unfavorable factors for both survival and LC of RT sites. Sex (male), performance status (≥3), and RT dose (BED10) (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsHumansMaleFemaleAgedPrognosisBone and BonesRadiotherapy DosageTomography, X-Ray Computed

Stichwörter der Autor:innen

bone metastasisexternal beam radiotherapylaboratory datalocal controlprognosis

Autor:innen und Institutionen

  • Department of Radiology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon 791-0295, Ehime, Japan.
  • Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou-160, Minami-Umenomoto-Machi, Matsuyama 791-0280, Ehime, Japan.

Zitieren

APA

Makita, K., Hamamoto, Y., Kanzaki, H., Nagasaki, K., Takata, N., Tsuruoka, S., Uwatsu, K., & Kido, T. (2023). Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy. Medical Sciences. https://doi.org/10.3390/medsci11010017

Vancouver

Makita K, Hamamoto Y, Kanzaki H, Nagasaki K, Takata N, Tsuruoka S, et al. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy. Medical Sciences. 2023. doi:10.3390/medsci11010017

BibTeX
@article{Makita2023,
  author = {Makita, Kenji and Hamamoto, Yasushi and Kanzaki, Hiromitsu and Nagasaki, Kei and Takata, Noriko and Tsuruoka, Shintaro and Uwatsu, Kotaro and Kido, Teruhito},
  title = {Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy},
  journal = {Medical Sciences},
  year = {2023},
  doi = {10.3390/medsci11010017}
}
Kostenlos starten →